Cargando…

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer

BACKGROUND: Conditional survival accounts for the time already survived after surgery and may be of additional informative value. The aim was to assess conditional survival in patients with oesophageal cancer and to create a nomogram predicting the conditional probability of survival after oesophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagens, E. R. C., Feenstra, M. L., Eshuis, W. J., Hulshof, M. C. C. M., van Laarhoven, H. W. M., van Berge Henegouwen, M. I., Gisbertz, S. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317937/ https://www.ncbi.nlm.nih.gov/pubmed/32017047 http://dx.doi.org/10.1002/bjs.11476

Ejemplares similares

Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment
por: Hagens, Eliza R.C., et al.
Publicado: (2020)

C-Reactive Protein as a Negative Predictive Marker for Anastomotic Leakage After Minimally Invasive Esophageal Surgery
por: Hagens, Eliza R. C., et al.
Publicado: (2023)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma
por: Jezerskyte, E, et al.
Publicado: (2020)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

Long-Term Quality of Life Following Transthoracic and Transhiatal Esophagectomy for Esophageal Cancer
por: Jezerskyte, E., et al.
Publicado: (2020)

Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study
por: Schuring, N, et al.
Publicado: (2022)

Thromboembolic and bleeding complications in patients with oesophageal cancer
por: Mulder, F. I., et al.
Publicado: (2020)

Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study
por: Keywani, Kammy, et al.
Publicado: (2023)

Preoperative Risk Stratification in Esophageal Cancer Surgery: Comparing Risk Models with the Clinical Judgment of the Surgeon
por: Hagens, Eliza R. C., et al.
Publicado: (2023)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment
por: Fabbi, M, et al.
Publicado: (2020)

Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review
por: Hagens, Eliza R. C., et al.
Publicado: (2020)

Optimal Perioperative Pain Management in Esophageal Surgery: An Evaluation of Paravertebral Analgesia
por: Feenstra, Minke L., et al.
Publicado: (2021)

Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP)
por: Jezerskyte, E., et al.
Publicado: (2021)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey
por: van Rijswijk, A. S., et al.
Publicado: (2019)

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: de Jongh, M, et al.
Publicado: (2021)

Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison
por: Eyck, Ben M, et al.
Publicado: (2022)

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer
por: Vollenbrock, S. E., et al.
Publicado: (2019)

Clinical implications of chyle leakage following esophagectomy
por: Schafrat, Pascale J M, et al.
Publicado: (2022)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

The role of fluorescence angiography in colonic interposition after esophagectomy
por: Joosten, J J, et al.
Publicado: (2022)

Contrast-Enhanced Radiologic Evaluation of Gastric Conduit Emptying After Esophagectomy
por: Feenstra, Minke L., et al.
Publicado: (2022)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2
por: van der Zijden, Charlène J., et al.
Publicado: (2023)

Improved anastomotic leakage rates after the “flap and wrap” reconstruction in Ivor Lewis esophagectomy for cancer
por: Slaman, Annelijn E, et al.
Publicado: (2022)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
por: Noordman, Bo Jan, et al.
Publicado: (2018)

Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
por: Slooter, M D, et al.
Publicado: (2020)

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
por: van der Wilk, B. J., et al.
Publicado: (2020)

Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study
por: Hermus, Merel, et al.
Publicado: (2022)

Compliance to D2 lymphadenectomy in laparoscopic gastrectomy
por: Eshuis, Wietse J., et al.
Publicado: (2018)

Endoscopic vacuum therapy for anastomotic leakage after upper gastrointestinal surgery
por: Pattynama, Lisanne M. D., et al.
Publicado: (2023)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

Transthoracic Versus Transhiatal Esophagectomy for Esophageal Cancer: A Nationwide Propensity Score-Matched Cohort Analysis
por: Mertens, Alexander C., et al.
Publicado: (2020)

Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis
por: Hagens, Eliza, et al.
Publicado: (2021)

Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy
por: Yoshikawa, R, et al.
Publicado: (2008)

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
por: Eyck, Ben M., et al.
Publicado: (2021)

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study
por: Borggreve, A. S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3lr3f3dhiu4k2oqit68ijqdrtc